drugset / Trial / NCT00003343

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

NCT00003343

Phase 3 Completed 525 enrolled Pfizer
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether mitoxantrone and prednisone are more effective with or without prinomastat in treating patients with metastatic prostate cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of mitoxantrone and prednisone with or without prinomastat in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Timeline

Start
1998-03
Primary completion
2001-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject prinomastat Small molecule Oral
Background Mitoxantrone Small molecule Intravenous
Background Prednisone Other / unclassified Oral

Indications